Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacokinetics of Levosimendan in Children with Acute Heart Failure
2012-000588-26Phase 4Active
- Sponsor
- Leiden University Medical Center
- Start
- Oct 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of levosimendan in Acute Heart Failure (AHF), sponsored by Leiden University Medical Center. Primary endpoint: Serum levels of levosimendan and its metabolites. Started Oct 2012; status: active.
02
Drugs
levosimendan
03
Conditions
Acute Heart Failure (AHF)
Beyond the preview
Go deeper on 2012-000588-26.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-000588-26.